Ritlecitinib + Rifampin Interaction
Moderateinteraction on record
Description
Strong CYP3A inducer may decrease AUC and Cmax of ritlecitinib, resulting in loss of or reduced clinical response. Coadministration is not recommended.
Mechanism
CYP3A induction
Source: NLP:ritlecitinib